Autolus Therapeutics

1.31
-0.09 (-6.43%)
At close: Apr 25, 2025, 3:59 PM
1.36
3.42%
After-hours: Apr 25, 2025, 05:36 PM EDT

Autolus Therapeutics Revenue Breakdown

Period Ending Sep 30, 2024 Mar 31, 2024 Dec 31, 2020 Sep 30, 2020
License Revenue n/a 10.1M n/a 242K
License Revenue Growth -100.00% n/a -100.00% n/a

Revenue by Geography

Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
United States Revenue 1.35M 6.19M 1.51M
United States Revenue Growth -78.17% +311.02% n/a

Operating Expense Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016
Selling, General, and Administrative Revenue 27.33M 21.9M 16.37M 13.95M 10.61M 11.12M 9.28M 7.41M 8.23M 8.27M 7.99M 7.59M 8.3M 7.24M 8.74M 9.01M 9.84M 8.51M 7.61M 9.92M 8.61M 11.37M 9.56M 7.59M 7.27M 6.8M 4.33M 2.89M 2.89M 1.66M 1.66M
Selling, General, and Administrative Revenue Growth +24.78% +33.79% +17.33% +31.50% -4.59% +19.80% +25.26% -9.95% -0.46% +3.53% +5.22% -8.53% +14.67% -17.18% -2.98% -8.50% +15.68% +11.75% -23.25% +15.29% -24.32% +18.98% +25.85% +4.40% +6.91% +57.11% +50.03% 0.00% +73.49% 0.00% n/a
Research and Development Revenue 40.32M 36.61M 30.67M 25.16M 37.24M 36.74M 31.34M 32.19M 37.63M 38.21M 33.96M 39.63M 32.29M 32.13M 30.73M 38.73M 33.55M 31.33M 31.29M 29.37M 27.31M 26.17M 22.57M 17.71M 10.15M 8.86M 11.69M 4.6M 4.6M 3.51M 3.51M
Research and Development Revenue Growth +10.14% +19.37% +21.91% -32.44% +1.35% +17.22% -2.62% -14.47% -1.52% +12.51% -14.31% +22.74% +0.50% +4.56% -20.65% +15.45% +7.08% +0.13% +6.53% +7.54% +4.34% +15.99% +27.39% +74.53% +14.51% -24.20% +154.17% 0.00% +31.20% 0.00% n/a